Top News

Road sign displaying the words Fast Track against a blue sky

RESEARCH

16 Jan 2026

FDA Fast Tracks Dual-Action MASH Drug: Is Momentum Back?

FDA grants two expedited reviews to a dual-action MASH drug, reviving interest in metabolic approaches without signaling a policy overhaul

Close-up of GLP-1 text under magnifying glass with obesity and diabetes terms

MARKET TRENDS

5 Feb 2026

Patients Take the Lead in US Metabolic Drug Pricing

PARTNERSHIPS

3 Feb 2026

AstraZeneca Brings AI In-House to Speed Drug Discovery

Latest News

PARTNERSHIPS
24 Feb 2026
Lilly Deepens AI Push in Obesity Drug Race
INVESTMENT
23 Feb 2026
Another Shot in the Obesity Gold Rush
MARKET TRENDS
19 Feb 2026
Precision Medicine Rises as Biomarkers Drive Change
PARTNERSHIPS
17 Feb 2026
Pfizer Steps Up Obesity Push With Metsera Deal

AI Drugmaker Targets Obesity Beyond GLP-1

Insilico Medicine office entrance with AI branding and corporate signage

INSIGHTS

16 Feb 2026

Insilico advances oral GIP candidate, signalling wider competition in weight-loss treatments

RESEARCH

21 Jun 2025

Stem Cell Trial Offers Hope for Insulin-Free Diabetes

Vertex's zimislecel left most trial patients insulin-free after a year, but safety risks and scalability remain major hurdles

8 9

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.